Anxiety disorders are associated with increased plasma adrenomedullin level and left ventricular hypertrophy in patients with hypertension

References

• Yilmaz M, Unsal A, Oztekin E, et al. The prevalence of hypertension, valve calcification and left ventricular hypertrophy and geometry in peritoneal dialysis patients. Kidney Blood Press Res 2012;35:431–7
   PubMed Web of Science ®Google Scholar
• Wei TM, Wang L. Anxiety symptoms in patients with hypertension: a community-based study. Int J Psychiatry Med 2006;36:315–22
   PubMed Web of Science ®Google Scholar
• Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med 2002;64:758–66
   PubMed Web of Science ®Google Scholar
• Kayano H, Koba S, Matsui T, et al. Anxiety disorder is associated with nocturnal and early morning hypertension with or without morning surge: ambulatory blood pressure monitoring. Circ J 2012;76:1670–7
   PubMed Web of Science ®Google Scholar
• Ma LL, Kong DG, Qi XW, Wang LX. Generalized anxiety disorder and the circadian rhythm of blood pressure in patients with hypertension. International Journal of Psychiatry in Clinical Practice 2008;12:292–5
   PubMed Web of Science ®Google Scholar
• Piccirillo G, Elvira S, Viola E, et al. Autonomic modulation of heart rate and blood pressure in hypertensive subjects with symptoms of anxiety. Clin Sci (Lond) 1998;95:43–52
   PubMed Web of Science ®Google Scholar
• Ginty AT, Carroll D, Roseboom TJ, et al. Depression and anxiety are associated with a diagnosis of hypertension 5 years later in a cohort of late middle-aged men and women. J Hum Hypertens 2013;27:187--90
   PubMed Web of Science ®Google Scholar
• Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the national health and nutrition examination survey i epidemiologic follow-up study. Arch Fam Med 1997;6:43–9
   PubMedGoogle Scholar
• Bajko Z, Szekeres CC, Kovacs KR, et al. Anxiety, depression and autonomic nervous system dysfunction in hypertension. J Neurol Sci 2012;317:112–16
   PubMed Web of Science ®Google Scholar
• Saboya PM, Zimmermann PR, Bodanese LC. Association between anxiety or depressive symptoms and arterial hypertension, and their impact on the quality of life. Int J Psychiatry Med 2010;40:307–20
   PubMed Web of Science ®Google Scholar
• Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192–217
   PubMed Web of Science ®Google Scholar
• Brown AD, Barton DA, Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 2009;23:583–602
   PubMed Web of Science ®Google Scholar
• Beltowski J, Jamroz A. Adrenomedullin – what do we know 10 years since its discovery? Pol J Pharmacol 2004;56:5–27
   PubMedGoogle Scholar
• Kato J, Kitamura K, Eto T. Plasma adrenomedullin level and development of hypertension. J Hum Hypertens 2006;20:566–70
   PubMed Web of Science ®Google Scholar
• Al-Omari MA, Khaleghi M, Mosley TH Jr, et al. Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in african americans with hypertension. Am J Hypertens 2009;22:860–6
   PubMed Web of Science ®Google Scholar
• Bhandari SS, Davies JE, Struck J, Ng LL. The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension. Metabolism 2010;59:7–13
   PubMed Web of Science ®Google Scholar
• Coutinho T, Al-Omari M, Mosley TH Jr, Kullo IJ. Biomarkers of left ventricular hypertrophy and remodeling in blacks. Hypertension 2011;58:920–5
   PubMed Web of Science ®Google Scholar
• Nishida H, Horio T, Suzuki Y, et al. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with c-reactive protein and adiponectin. Peptides 2008;29:599–605
   PubMed Web of Science ®Google Scholar
• Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry 2001;62 Suppl 8:24–7
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al. The task force for the management of arterial hypertension of the European Society of H, The task force for the management of arterial hypertension of the European Society of C. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (esh) and of the european society of cardiology (esc). Eur Heart J 2007;28:1462–536
   PubMed Web of Science ®Google Scholar
• Ma ZS, Ma SJ, Dong MF, et al. Effect of captopril on pulmonary artery pressure following corrective surgery for tetralogy of fallot. J Card Surg 2009;24:553–7
   PubMed Web of Science ®Google Scholar
• Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358–67
   PubMed Web of Science ®Google Scholar
• Koziolova NA, Shatunova IM, Lazarev IA. [risk factors of development of left ventricular hypertrophy in patients with hypertensive disease with high compliance to treatment]. Kardiologiia 2012;52:25–30
   PubMed Web of Science ®Google Scholar
• Salvetti G, Pucci A, Fierabracci P, et al. Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev 2012;19:33–9
   Google Scholar
• Thanassoulis G, Lyass A, Benjamin EJ, et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the framingham heart study. Circulation 2012;125:2836–43
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Facchetti R, Sala C, et al. Normal values of left-ventricular mass: echocardiographic findings from the pamela study. J Hypertens 2012;30:997–1003
   PubMed Web of Science ®Google Scholar
• Kario K, Nishikimi T, Yoshihara F, et al. Plasma levels of natriuretic peptides and adrenomedullin in elderly hypertensive patients: relationships to 24 h blood pressure. J Hypertens 1998;16:1253–9
   PubMed Web of Science ®Google Scholar
• Owens PE, Lyons SP, Rodriguez SA, O’Brien ET. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J Hum Hypertens 1998;12:743–8
   PubMed Web of Science ®Google Scholar
• Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 2000;35:S1–7
   PubMed Web of Science ®Google Scholar